Clinical Trial Update: Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin and paclitaxel with or without cediranib maleate in metastatic or recurrent cervical cancer that cannot be removed by surge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cediranib Maleate (cediranib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Glasgow | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED